# Novo Nordisk Fonden

**Type:** Funders  
**Canonical URL:** https://scholariq.org/funders/novo-nordisk-fonden/

## Facts

| Field | Value |
| --- | --- |
| Country | DK |
| OpenAlex ID | https://openalex.org/F4320325957 |
| ROR ID | https://ror.org/04txyc737 |
| Works | 45,663 |

## Funder papers

- [Effects of once-weekly subcutaneous semaglutide on kidney function and safety in patients with type 2 diabetes: a post-hoc analysis of the SUSTAIN 1–7 randomised controlled trials](https://scholariq.org/papers/effects-of-once-weekly-subcutaneous-semaglutide-on-kidney-function-and-safety-in/)
- [Severity of COVID-19 at elevated exposure to perfluorinated alkylates](https://scholariq.org/papers/severity-of-covid-19-at-elevated-exposure-to-perfluorinated-alkylates/)
- [Adherence to medication in patients with chronic kidney disease: a systematic review of qualitative research](https://scholariq.org/papers/adherence-to-medication-in-patients-with-chronic-kidney-disease-a-systematic/)
- [Standardized measurement of coronary inflammation using cardiovascular computed tomography: integration in clinical care as a prognostic medical device](https://scholariq.org/papers/standardized-measurement-of-coronary-inflammation-using-cardiovascular-computed/)
- [The use of sodium-glucose co-transporter-2 inhibitors or glucagon-like peptide-1 receptor agonists versus sulfonylureas and the risk of lower limb amputations: a nation-wide cohort study](https://scholariq.org/papers/the-use-of-sodium-glucose-co-transporter-2-inhibitors-or-glucagon-like-peptide-1/)
- [ESPGHAN 54th Annual Meeting Abstracts](https://scholariq.org/papers/espghan-54th-annual-meeting-abstracts/)
- [Abstracts](https://scholariq.org/papers/abstracts/)
- [Insulin therapy and outcomes of revascularization procedures for chronic limb-threatening ischemia in the BEST-CLI trial](https://scholariq.org/papers/insulin-therapy-and-outcomes-of-revascularization-procedures-for-chronic-limb/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.